Found: 17
Select item for more details and to access through your institution.
GOLD assessment of COPD severity in the Clinical Practice Research Datalink (CPRD).
- Published in:
- Pharmacoepidemiology & Drug Safety, 2019, v. 28, n. 2, p. 126, doi. 10.1002/pds.4448
- By:
- Publication type:
- Article
ACCORD COPD II: A Randomized Clinical Trial to Evaluate the 12-Week Efficacy and Safety of Twice-Daily Aclidinium Bromide in Chronic Obstructive Pulmonary Disease Patients.
- Published in:
- Clinical Drug Investigation, 2013, v. 33, n. 12, p. 893, doi. 10.1007/s40261-013-0138-1
- By:
- Publication type:
- Article
Baseline type 2 biomarker levels and response to tezepelumab in severe asthma.
- Published in:
- Allergy, 2022, v. 77, n. 6, p. 1786, doi. 10.1111/all.15197
- By:
- Publication type:
- Article
Benralizumab improves symptoms of patients with severe, eosinophilic asthma with a diagnosis of nasal polyposis.
- Published in:
- Allergy, 2022, v. 77, n. 1, p. 150, doi. 10.1111/all.14902
- By:
- Publication type:
- Article
The Pharmacokinetics, Safety and Tolerability of Aclidinium Bromide 400 μg Administered by Inhalation as Single and Multiple (Twice Daily) Doses in Healthy Chinese Participants.
- Published in:
- International Journal of COPD, 2023, v. 18, p. 2725, doi. 10.2147/COPD.S434588
- By:
- Publication type:
- Article
The Impact of Exacerbation History on the Safety and Efficacy of Aclidinium in Patients with Chronic Obstructive Pulmonary Disease and Increased Cardiovascular Risk: ASCENT-COPD Trial.
- Published in:
- International Journal of COPD, 2021, v. 16, p. 689, doi. 10.2147/COPD.S285068
- By:
- Publication type:
- Article
The Impact of Lebrikizumab on Vaccine-Induced Immune Responses: Results from a Phase 3 Study in Adult Patients with Moderate-to-Severe Atopic Dermatitis.
- Published in:
- Dermatology & Therapy, 2024, v. 14, n. 8, p. 2181, doi. 10.1007/s13555-024-01217-w
- By:
- Publication type:
- Article
Efficacy of Aclidinium Bromide According to Baseline Therapy: Post-Hoc Analysis of ASCENT-COPD Randomized Trial.
- Published in:
- Advances in Therapy, 2021, v. 38, n. 10, p. 5381, doi. 10.1007/s12325-021-01878-5
- By:
- Publication type:
- Article
Ability of Serum IgE Concentration to Predict Exacerbation Risk and Benralizumab Efficacy for Patients with Severe Eosinophilic Asthma.
- Published in:
- 2020
- By:
- Publication type:
- journal article
Impact of night-time symptoms in COPD: a real-world study in five European countries.
- Published in:
- International Journal of COPD, 2013, v. 8, p. 595, doi. 10.2147/COPD.S48570
- By:
- Publication type:
- Article
Aclidinium bromide and formoterol fumarate as a fixed-dose combination in COPD: pooled analysis of symptoms and exacerbations from two six-month, multicentre, randomised studies (ACLIFORM and AUGMENT).
- Published in:
- Respiratory Research, 2015, v. 16, n. 1, p. 1, doi. 10.1186/s12931-015-0250-2
- By:
- Publication type:
- Article
NAVIGATOR: a phase 3 multicentre, randomized, double-blind, placebo-controlled, parallel-group trial to evaluate the efficacy and safety of tezepelumab in adults and adolescents with severe, uncontrolled asthma.
- Published in:
- 2020
- By:
- Publication type:
- journal article
SOURCE: a phase 3, multicentre, randomized, double-blind, placebo-controlled, parallel group trial to evaluate the efficacy and safety of tezepelumab in reducing oral corticosteroid use in adults with oral corticosteroid dependent asthma.
- Published in:
- 2020
- By:
- Publication type:
- journal article
Aclidinium improves exercise endurance, dyspnea, lung hyperinflation, and physical activity in patients with COPD: a randomized, placebo-controlled, crossover trial.
- Published in:
- 2014
- By:
- Publication type:
- journal article
An Evaluation of the Pharmacokinetics, Safety, and Tolerability of Aclidinium/Formoterol Fixed-Dose Combination Administered in Chinese Patients with Moderate-to-Severe Chronic Obstructive Pulmonary Disease.
- Published in:
- Drugs in R&D, 2022, v. 22, n. 1, p. 35, doi. 10.1007/s40268-021-00374-z
- By:
- Publication type:
- Article
Reduction in clinically important deterioration in chronic obstructive pulmonary disease with aclidinium/formoterol.
- Published in:
- 2017
- By:
- Publication type:
- journal article
The effect of aclidinium bromide on daily respiratory symptoms of COPD, measured using the Evaluating Respiratory Symptoms in COPD (E-RS: COPD) diary: pooled analysis of two 6-month Phase III studies.
- Published in:
- 2016
- By:
- Publication type:
- journal article